Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-030693

Options or other derivatives

  • President & CEO acquired 182,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Stonehouse Jon P President & CEO 2020-12-03 Grant or award · Emp. Stock Option (Right to Buy) +25,000 25,000 D: show line 1 in the form
Stonehouse Jon P President & CEO 2020-12-03 Grant or award · Emp. Stock Option (Right to Buy) +157,250 157,250 D: show line 2 in the form
Loading xslF345X03/form4.xml…